G
o
o
g
l
e
×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
AstraZeneca plans independent drug supply chains for US and China, CEO says
Fierce Pharma
As geopolitical tensions threaten to disrupt pharmaceutical supply chains, AstraZeneca is making plans to manufacture drugs for the U.S. and...
1 day ago
AstraZeneca claims Australian rules stopped it defending its vaccine during pandemic
The Guardian
Company says TGA regulations prevented it from responding to incorrect claims about its vaccine in 2021.
8 hours ago
AstraZeneca’s Ultomiris Wins FDA Approval for Rare Autoimmune Disease
BioSpace
AstraZeneca's Alexion on Monday secured the fourth indication for Ultomiris, which can now be used to treat the rare autoimmune condition...
2 days ago
AstraZeneca's (AZN) Ultomiris Gets FDA Nod for New Indication
Yahoo Finance
FDA approves AstraZeneca's (AZN) Ultomiris for AQP4 Ab+ NMOSD, making it the first and only long-acting C5 complement inhibitor approved for...
2 days ago
AstraZeneca sues Arkansas over role of pharmacies in discount drug program
STAT
The move comes less than a month after a U.S. appeals court upheld the same state law and its mandate for the 340b drug discount program.
1 day ago
AstraZeneca CEO 'deeply humbled' by award recognising pandemic efforts
biopharma-reporter.com
AstraZeneca CEO Sir Pascal Soriot has been awarded one of the highest honours by science institution SCI for his role in 'accelerating...
21 hours ago
AstraZeneca’s Ultomiris receives FDA approval to treat rare autoimmune disease NMOSD
PMLiVE
Neuromyelitis optica spectrum disorder is estimated to affect approximately 6,000 adults in the US. - PMLiVE. AstraZeneca's (AZ) Ultomiris...
2 days ago
Astra, Pfizer Boost China Bets Despite US Drive to Decouple
Bloomberg
The chief executive officers of AstraZeneca Plc and Pfizer Inc. pledged to support expansion of China's biopharmaceutical industry,...
3 days ago
Japan approves AstraZeneca's Truqap combo for breast cancer
Pharmaceutical Technology
The Japanese MHLW has approved AstraZeneca's Truqap (capivasertib) plus Faslodex (fulvestrant) for treating a specific type of breast...
24 hours ago
AstraZeneca falls Thursday, underperforms market
MarketWatch
AstraZeneca PLC shares inched down 0.60% to £106.78 Thursday, on what proved to be an all-around positive trading session for the stock...
14 hours ago